Clinical trial
Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)
NCT00933738 is registered in ClinicalTrials.gov with Abbott RDx Cardiometabolic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)
- Lead sponsor
- Abbott RDx Cardiometabolic
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- March 31, 2011
- Enrollment
- 150 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
coagulation